Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05714033 · ClinicalTrials.gov registry record · NA
A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)
A NA study of Pulmonary and Lung, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05714033: Recruiting NA study of Pulmonary and Lung, sponsored by M.D. Anderson Cancer Center.
NCT05714033 is a NA study of Pulmonary and Lung that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05714033, a NA study of Pulmonary and Lung, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.
Interventions
- PROCEDURE Ventilatory Strategy To Prevent Atelectasis
- PROCEDURE Lateral Decubitus Strategy (LADS)
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-02-10 |
| Est. Completion | 2032-09-14 |
| Phase | NA |
What NCT05714033 shows while recruiting
NCT05714033 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Pulmonary appearing as the primary indexed condition, and to 2 interventions - of which Ventilatory Strategy To Prevent Atelectasis is the first listed.
NCT05714033 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05714033 about?
NCT05714033 is a clinical study titled "A Randomized Trial Comparing a Ventilatory Strategy To Prevent Atelectasis Versus a Lateral Decubitus Strategy During Robotic Bronchoscopy (VESPA vs. LADS Trial)". To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.
What is the current status of trial NCT05714033?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-02-10. Estimated completion is 2032-09-14.
What conditions does trial NCT05714033 study?
This clinical trial studies the following conditions: Pulmonary, Lung.
What interventions are being tested in trial NCT05714033?
The interventions under investigation include: Ventilatory Strategy To Prevent Atelectasis (PROCEDURE), Lateral Decubitus Strategy (LADS) (PROCEDURE).
Who is sponsoring clinical trial NCT05714033?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05714033 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05714033's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI